anti-Chlamydia trachomatis (MOMP) antibody product blog
Tags: Antibody; Polyclonal Antibody; Chlamydia trachomatis (MOMP); anti-Chlamydia trachomatis (MOMP) antibody;
The Chlamydia trachomatis (MOMP) n/a (Catalog #MBS315117) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Chlamydia trachomatis (MOMP) can be used in a range of immunoassay formats including, but not limited to, Immunofluorescence Assay.Suitable for use in fluorescence microscopy. Also suitable for conjugation purposes. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded. Researchers should empirically determine the suitability of the Chlamydia trachomatis (MOMP) n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Purified MOMP from strain L2. Buffer: 0.01M PBS pH 7.2
No stabilizing proteins were added.
Preservative: 0.1% Sodium azide
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Chlamydia trachomatis (MOMP) are readily searchable from our website. Different antibodies against the same target such as Chlamydia trachomatis (MOMP) may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.